Moneycontrol PRO
you are here: HomeNewsCorbevax
corbevax
Jump to
  • Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO Sep 12, 2022 04:06 PM IST

    Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO

    The managing director of vaccine manufacturing company says regulatory framework along with financing and market predictability are important bottlenecks in developing variant specific vaccines against evolving coronavirus

  • COVID-19 booster dose drive fails to pick up, only one in five eligible adults jabbed Aug 31, 2022 11:15 AM IST

    COVID-19 booster dose drive fails to pick up, only one in five eligible adults jabbed

    Meghalaya has the worst 8 percent coverage of the Covid booster dose among its eligible population, while Andhra Pradesh has the highest at 34 percent

  • Omicron sub-variant BA.2.75 dominant in Delhi; caution advised for those with low immunity, underlying diseases  Aug 17, 2022 11:40 AM IST

    Omicron sub-variant BA.2.75 dominant in Delhi; caution advised for those with low immunity, underlying diseases 

    Sometimes referred to as the Centaurus, Omicron sub-variant BA.2.75 was first detected in May in India but has since been identified in at least 20 other countries

  • From August 12, option of Corbevax as booster doses for all jabbed with Covaxin, Covishield earlier Aug 10, 2022 07:01 PM IST

    From August 12, option of Corbevax as booster doses for all jabbed with Covaxin, Covishield earlier

    The recipients of Covaxin and Covishield, however, will also have an option of receiving the same vaccine they had taken for their primary vaccination

  • Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield Aug 10, 2022 11:13 AM IST

    Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

    This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.

  • Government nod for Corbevax as booster for adults vaccinated with Covishield, Covaxin soon Aug 09, 2022 06:02 PM IST

    Government nod for Corbevax as booster for adults vaccinated with Covishield, Covaxin soon

    According to official sources, the Union health ministry will soon approve Biological E's Corbevax as a precautionary dose for adults who have received both Covishield and Covaxin vaccinations.

  • Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin Aug 02, 2022 07:02 PM IST

    Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin

    According to official sources, a government commission on Covid immunisation has advised enabling people who have received the complete course of either Covishield or Covaxin vaccination to take Biological E's Corbevax as a precautionary dose.

  • Political will at the top and community participation at the bottom drove India's COVID-19 vaccination campaign: Dr N K Arora Jul 18, 2022 12:19 PM IST

    Political will at the top and community participation at the bottom drove India's COVID-19 vaccination campaign: Dr N K Arora

    On July 17, India administered its 2 billionth COVID-19 vaccine dose, 18 months after the mammoth vaccination drive against coronavirus was launched. Of the total doses administered, 51 percent doses were given to women and 71 percent vaccination centres were in rural areas

  • Corbevax as booster dose after Covaxin, Covishield? Top panel on immunisation to discuss possibility Jul 12, 2022 12:42 PM IST

    Corbevax as booster dose after Covaxin, Covishield? Top panel on immunisation to discuss possibility

    Last year, the Union government had paid an advance of Rs 1,500 crore to Corbevax maker Biological E to procure 30 crore doses of the vaccine, which was still in phase 3 clinical trials, in the first such deal to secure a vaccine.

  • Moneycontrol Selects: Top stories this evening Jul 08, 2022 06:22 PM IST

    Moneycontrol Selects: Top stories this evening

    Our specially curated package of the most interesting articles to help you stay at the top of your game.

  • NTAGI's technical sub-committee recommends use of Corbevax, Covaxin for children between 5-12 years Jul 08, 2022 05:44 PM IST

    NTAGI's technical sub-committee recommends use of Corbevax, Covaxin for children between 5-12 years

    Biological E’s Corbevax has been recommended for administration in 5 to 12 years old children, while the Bharat Biotech’s Covaxin has been recommended for children in 6-12 years’ age group.

  • Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin  Jun 06, 2022 01:30 PM IST

    Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin 

    The pharma regulator has approved the first mix-and-match of COVID-19 vaccines in India, but the final say-so lies with the government 

  • Moneycontrol Daily: Your Essential 7 Jun 05, 2022 07:19 AM IST

    Moneycontrol Daily: Your Essential 7

    A daily round-up of the most interesting articles to help jump-start the day.

  • Moneycontrol Selects: Top stories this evening Jun 04, 2022 06:54 PM IST

    Moneycontrol Selects: Top stories this evening

    Our specially curated package of the most interesting articles of the day will help you stay at the top of your game.

  • COVID-19 Vaccine | Corbevax gets DCGI nod as heterologous booster dose Jun 04, 2022 05:12 PM IST

    COVID-19 Vaccine | Corbevax gets DCGI nod as heterologous booster dose

    COVID-19 Vaccine: With this, Corbevax becomes the first vaccine approved as a heterologous Covid-19 booster.

  • Covid-19: 10 crore doses of SII's Covovax approved for exports by govt lab, stock rolled out for teens May 05, 2022 09:36 PM IST

    Covid-19: 10 crore doses of SII's Covovax approved for exports by govt lab, stock rolled out for teens

    Covovax, the Covid-19 vaccine manufactured by the Serum Institute of India under licence from US firm Novavax, will be available at Rs 225 per dose, excluding taxes, at private healthcare facilities.

  • Exclusive: Supplied nearly 100 million doses to Govt; committed to meeting growing demand for Corbevax: Biological E’s COO Apr 29, 2022 08:53 AM IST

    Exclusive: Supplied nearly 100 million doses to Govt; committed to meeting growing demand for Corbevax: Biological E’s COO

    Data on the Omicron variant in children was not part of our clinical trial endpoints. We have submitted all the data generated against multiple variants to regulatory agencies including NTAGI. We are regularly making presentations to the regulatory bodies as more and more data gets generated, says Lakshminarayana Neti

  • Will wait for NTAGI’s nod before administering COVID-19 vaccine in 5-12 age group: Health Minister Apr 28, 2022 05:29 PM IST

    Will wait for NTAGI’s nod before administering COVID-19 vaccine in 5-12 age group: Health Minister

    When asked if the gap for taking the booster dose has been reduced from nine months to six, the minister said, NTAGI is the panel to take decisions in this regard.

  • COVID-19 vaccines for 5-11-year-olds may be limited to private hospitals  Apr 27, 2022 11:46 AM IST

    COVID-19 vaccines for 5-11-year-olds may be limited to private hospitals 

    Government approval for the administration of COVID-19 vaccines to children in the 5-11-year age group is possible as early as next week, according to health ministry officials familiar with the situation. 

  • Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away Mar 23, 2022 03:17 PM IST

    Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away

    Private healthcare providers struggling to use up their stocks of Covishield and Covaxin shots are showing no enthusiasm for the Corbevax vaccination of children.

  • Over 23,000 children aged 12-14 years received first dose of Corbevax vaccine Mar 16, 2022 10:32 PM IST

    Over 23,000 children aged 12-14 years received first dose of Corbevax vaccine

    The Centre has asked states to organise dedicated Covid vaccination sessions through earmarked centres and train vaccinators to avoid mixing of vaccines during the inoculation of children in the 12-14 age group.

  • COVID-19 Vaccine | Govt to procure Corbevax at Rs 290 for two doses, private hospitals at Rs 800 Mar 16, 2022 04:18 PM IST

    COVID-19 Vaccine | Govt to procure Corbevax at Rs 290 for two doses, private hospitals at Rs 800

    On March 16, India began the inoculation drive for children aged 12 to 14 years, administering only the Corbevax COVID-19 vaccine to the beneficiaries.

  • COVID-19 | India begins vaccinating children aged 12-14 years Mar 16, 2022 04:03 PM IST

    COVID-19 | India begins vaccinating children aged 12-14 years

    On March 16, the inoculation of children in the age group 12 to 14 against COVID-19 started with the administered Corbevax vaccine against COVID-19. Two doses of Biological E’s intramuscular Corbevax vaccine would be administered to the beneficiaries in an interval of 28 days.

  • COVID-19 vaccine for 12-14-year-olds to start from March 16; all above 60 years can take boosters Mar 14, 2022 01:55 PM IST

    COVID-19 vaccine for 12-14-year-olds to start from March 16; all above 60 years can take boosters

    The new decision will mean that, while Corbevax will be offered to the younger adolescents, those in the 15-17-year age group will continue to get Covaxin.

  • Cadila Healthcare falls as rival’s COVID-19 vaccine gets nod for emergency use on adolescents Feb 22, 2022 09:33 AM IST

    Cadila Healthcare falls as rival’s COVID-19 vaccine gets nod for emergency use on adolescents

    Prior to Biological E, Cadila Healthcare and Bharat Biotech’s Covaxin had received the regulator’s emergency approval for use on young adults.